IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,125,356 | -32.1% | 247,331 | +5.0% | 0.00% | 0.0% |
| Q2 2023 | $1,658,434 | +69.6% | 235,573 | +47.2% | 0.00% | +100.0% |
| Q1 2023 | $977,930 | -6.1% | 160,054 | -1.8% | 0.00% | -50.0% |
| Q4 2022 | $1,041,615 | -32.5% | 163,007 | +1.3% | 0.00% | -33.3% |
| Q3 2022 | $1,542,000 | -15.3% | 160,973 | -2.4% | 0.00% | 0.0% |
| Q2 2022 | $1,821,000 | -36.3% | 164,937 | -3.9% | 0.00% | -25.0% |
| Q1 2022 | $2,858,000 | -19.8% | 171,647 | -8.1% | 0.00% | 0.0% |
| Q4 2021 | $3,565,000 | -36.3% | 186,741 | -17.7% | 0.00% | -42.9% |
| Q3 2021 | $5,597,000 | -13.6% | 226,963 | -8.8% | 0.01% | -12.5% |
| Q2 2021 | $6,475,000 | -17.2% | 248,831 | +0.7% | 0.01% | -20.0% |
| Q1 2021 | $7,824,000 | -32.0% | 247,116 | -0.4% | 0.01% | -37.5% |
| Q4 2020 | $11,514,000 | +43.9% | 248,146 | +2.1% | 0.02% | +23.1% |
| Q3 2020 | $8,000,000 | +25.2% | 243,022 | +4.4% | 0.01% | +18.2% |
| Q2 2020 | $6,392,000 | +19.9% | 232,871 | +30.8% | 0.01% | 0.0% |
| Q1 2020 | $5,331,000 | +7.6% | 178,078 | -0.5% | 0.01% | +37.5% |
| Q4 2019 | $4,954,000 | +52.3% | 178,961 | +0.1% | 0.01% | +33.3% |
| Q3 2019 | $3,252,000 | -24.9% | 178,698 | +1.2% | 0.01% | -33.3% |
| Q2 2019 | $4,329,000 | +178.8% | 176,564 | +8.1% | 0.01% | +200.0% |
| Q1 2019 | $1,553,000 | +5.9% | 163,292 | -1.5% | 0.00% | 0.0% |
| Q4 2018 | $1,467,000 | +3.6% | 165,712 | +31.7% | 0.00% | 0.0% |
| Q3 2018 | $1,416,000 | -12.0% | 125,824 | +0.1% | 0.00% | 0.0% |
| Q2 2018 | $1,610,000 | -15.1% | 125,754 | +12.0% | 0.00% | -25.0% |
| Q1 2018 | $1,897,000 | +144.5% | 112,246 | +15.7% | 0.00% | +100.0% |
| Q4 2017 | $776,000 | +17.0% | 97,044 | +13.5% | 0.00% | +100.0% |
| Q3 2017 | $663,000 | -3.6% | 85,485 | -8.7% | 0.00% | 0.0% |
| Q2 2017 | $688,000 | – | 93,664 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |